Inventor · disambiguated record
Colin Correnti
Also filed as: CORRENTI COLIN · CORRENTI COLIN E
9 granted patents·13 pending applications·8 citations·filing 2013–2024
80Inventor score
Files withHUTCHINSON FRED CANCER RES11FRED HUTCHINSON CANCER CENTER8Fred Hutchison Cancer Center1LINK ASSIGNMENT FOR THE BENEFIT OF CREDITORS LLC1LINK IMMUNOTHERAPEUTICS INC1
Top patents by PatentIndex Score
22 records- 0188US11090358B2Cartilage-homing peptidesHUTCHINSON FRED CANCER RES·Filed 2016·Granted Aug 17, 2021·4 cites·27 claims
- 0277US10156559B2Lipocalin fusion partnersHUTCHINSON FRED CANCER RES·Filed 2013·Granted Dec 18, 2018·3 cites·22 claims
- 0372US2023364183A1Cartilage-homing peptidesFRED HUTCHINSON CANCER CENTER·Filed 2023·Application pending·0 cites
- 0471US11648290B2Cartilage-homing peptidesFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted May 16, 2023·0 cites·20 claims
- 0571US10342863B2Engineered and multimerized human immunodeficiency virus envelope glycoproteins and uses thereofHUTCHINSON FRED CANCER RES·Filed 2016·Granted Jul 9, 2019·1 cites·17 claims
- 0670US2024294663A1Anti-mesothelin antigen-binding molecules and uses thereofLINK ASSIGNMENT FOR THE BENEFIT OF CREDITORS LLC·Filed 2024·Application pending·0 cites
- 0770US2025034250A1Anti-cd33 antibodies and uses thereofFred Hutchison Cancer Center·Filed 2024·Application pending·0 cites
- 0866US11981745B2Anti-mesothelin antigen-binding molecules and uses thereofLINK IMMUNOTHERAPEUTICS INC·Filed 2023·Granted May 14, 2024·0 cites·26 claims
- 0966US10987417B2Engineered and multimerized human immunodeficiency virus envelope glycoproteins and uses thereofHUTCHINSON FRED CANCER RES·Filed 2019·Granted Apr 27, 2021·0 cites·11 claims
- 1060US2023398208A1SARS-CoV-2 VACCINES AND USES THEREOFFRED HUTCHINSON CANCER CENTER·Filed 2023·Application pending·0 cites
- 1157US12116406B2Anti-CD33 antibodies and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Oct 15, 2024·0 cites·11 claims
- 1257US11987640B2Anti-mesothelin antigen-binding molecules and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Granted May 21, 2024·0 cites·12 claims
- 1353US2024287147A1Pd-l1 binding peptides and peptide complexes and methods of use thereofFRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
- 1450US2019101528A1Lipocalin fusion partnersHUTCHINSON FRED CANCER RES·Filed 2018·Application pending·0 cites
- 1547US12351618B2Engineered trimeric CD70 proteins and uses thereofFRED HUTCHINSON CANCER CENTER·Filed 2020·Granted Jul 8, 2025·0 cites·18 claims
- 1647US2022411472A1Self-assembling circular tandem repeat proteins with increased stabilityFRED HUTCHINSON CANCER CENTER·Filed 2020·Application pending·0 cites
- 1741US2020330603A1Peptides for renal therapyHUTCHINSON FRED CANCER RES·Filed 2016·Application pending·0 cites
- 1840US2020188528A1Peptide-antibody compositions and methods of use thereofHUTCHINSON FRED CANCER RES·Filed 2017·Application pending·0 cites
- 1936US2018371033A1Therapeutic peptides and methods of use thereofHUTCHINSON FRED CANCER RES·Filed 2016·Application pending·0 cites
- 2036US2019233534A1Multiple bi-specific binding domain constructs with different epitope binding to treat cancerHUTCHINSON FRED CANCER RES·Filed 2017·Application pending·0 cites
- 2136US2019375786A1Stable peptides and methods of use thereofHUTCHINSON FRED CANCER RES·Filed 2017·Application pending·0 cites
- 2234US2019292243A1Peptides and methods of use thereofHUTCHINSON FRED CANCER RES·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Colin Correnti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →